Cover Image
Market Research Report

North America Clinical Nutrition Market By Route of Administration By Application By Country, Industry Analysis and Forecast, 2020 - 2026

Published by KBV Research Product code 941760
Published Content info 87 Pages
Delivery time: 1-2 business days
Price
Back to Top
North America Clinical Nutrition Market By Route of Administration By Application By Country, Industry Analysis and Forecast, 2020 - 2026
Published: May 31, 2020 Content info: 87 Pages
Description

Title:
North America Clinical Nutrition Market By Route of Administration (Oral, Enteral and Parenteral) By Application (Cancer, Neurological Diseases, Gastrointestinal Disorders, Metabolic Disorders and Other Applications) By Country, Industry Analysis and Forecast, 2020 - 2026.

The North America Clinical Nutrition Market would witness market growth of 6.2% CAGR during the forecast period (2020-2026).

Nutrition and diet are an important part of many health problems. A person is helped to preserve his health and wellbeing with a healthy diet and healthy intakes. Clinical nutrition is a form of nutrition for patients receiving medical care. Clinical nutrition is structured to preserve energy balance and provide essential nutrients such as calories, vitamins, and minerals. It also includes studies of nutrients important for the human body and the way the body is affected by nutrients.

Treatments for cancer can impair taste, smell, appetite, and ability to consume adequate food or absorb food nutrients. This can lead to malnutrition caused by a lack of important nutrients. The risk of malnutrition can rise with alcohol abuse and obesity. Malnutrition may contribute to fatigue, tiredness, and inability to fight illness or to end treatment of cancer. If cancer grows or spreads, malnutrition may become worse. This stresses the critical importance of clinical nutrition especially for treatment, infection control, and strength.

Neurological problems are also concerned with swallowing and starvation. In fact, the possibility of micronutrient loss and dehydration is enhanced for patients with neurological disorders. In comparison, the pathogenesis of neurological disorders may require dietary factors. The multiple causes of malnutrition are known for oropharyngeal dysphagia, impaired consciously, perception deficits, cognitive dysfunction, and increased need in neurological patients.

Based on Route of Administration, the market is segmented into Oral, Enteral and Parenteral. Based on Application, the market is segmented into Cancer, Neurological Diseases, Gastrointestinal Disorders, Metabolic Disorders and Other Applications. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, B. Braun Melsungen AG, Baxter International, Inc., Pfizer, Inc., Nestle S.A., Lonza Group AG, BASF SE, Ajinomoto Co., Inc., Perrigo Company PLC, and Hero Nutritionals, Inc.

Scope of the Study

Market Segmentation:

By Route of Administration

  • Oral
  • Enteral and
  • Parenteral

By Application

  • Cancer
  • Neurological Diseases
  • Gastrointestinal Disorders
  • Metabolic Disorders and
  • Other Applications

By Country

  • US
  • Canada
  • Mexico
  • Rest of North America

Companies Profiled:

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Baxter International, Inc.
  • Pfizer, Inc.
  • Nestle S.A.
  • Lonza Group AG
  • BASF SE
  • Ajinomoto Co., Inc.
  • Perrigo Company PLC
  • Hero Nutritionals, Inc.

Unique Offerings from KBV Research:

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free
Table of Contents

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 North America Clinical Nutrition Market, by Route of Administration
    • 1.4.2 North America Clinical Nutrition Market, by Application
    • 1.4.3 North America Clinical Nutrition Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
    • 2.1.2 Market Composition and Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global

  • 3.1 KBV Cardinal Matrix
  • 3.2 Recent Industry Wide Strategic Developments
    • 3.2.1 Partnerships, Collaborations and Agreements
    • 3.2.2 Product Launches and Product Expansions
    • 3.2.3 Mergers & Acquisitions
    • 3.2.4 Geographical Expansions
  • 3.3 Top Winning Strategies
    • 3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
    • 3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2016, Jan - 2019, Dec) Leading Players
    • 3.3.3 Key Strategic Move: (Product Launches and Product Expansions : 2016, Mar - 2019, Oct) Leading Players

Chapter 4. North America Clinical Nutrition Market by Route Of Administration

  • 4.1 North America Oral Market by Country
  • 4.2 North America Enteral Market by Country
  • 4.3 North America Parenteral Market by Country

Chapter 5. North America Clinical Nutrition Market by Application

  • 5.1 North America Cancer Market by Country
  • 5.2 North America Neurological Diseases Market by Country
  • 5.3 North America Gastrointestinal Disorders Market by Country
  • 5.4 North America Metabolic Disorders Market by Country
  • 5.5 North America Other Applications Market by Country

Chapter 6. North America Clinical Nutrition Market by End User

  • 6.1 North America Adults Clinical Nutrition Market by Country
  • 6.2 North America Pediatric Market by Country
  • 6.3 North America Geriatric Market by Country

Chapter 7. North America Clinical Nutrition Market by Country

  • 7.1 US Clinical Nutrition Market
    • 7.1.1 US Clinical Nutrition Market by Route Of Administration
    • 7.1.2 US Clinical Nutrition Market by Application
    • 7.1.3 US Clinical Nutrition Market by End User
  • 7.2 Canada Clinical Nutrition Market
    • 7.2.1 Canada Clinical Nutrition Market by Route Of Administration
    • 7.2.2 Canada Clinical Nutrition Market by Application
    • 7.2.3 Canada Clinical Nutrition Market by End User
  • 7.3 Mexico Clinical Nutrition Market
    • 7.3.1 Mexico Clinical Nutrition Market by Route Of Administration
    • 7.3.2 Mexico Clinical Nutrition Market by Application
    • 7.3.3 Mexico Clinical Nutrition Market by End User
  • 7.4 Rest of North America Clinical Nutrition Market
    • 7.4.1 Rest of North America Clinical Nutrition Market by Route Of Administration
    • 7.4.2 Rest of North America Clinical Nutrition Market by Application
    • 7.4.3 Rest of North America Clinical Nutrition Market by End User

Chapter 8. Company Profiles

  • 8.1 Abbott Laboratories
    • 8.1.1 Company Overview
    • 8.1.2 Financial Analysis
    • 8.1.3 Segmental and Regional Analysis
    • 8.1.4 Research & Development Expense
    • 8.1.5 Recent strategies and developments:
      • 8.1.5.1 Acquisition and Mergers:
      • 8.1.5.2 Product Launches and Product Expansions:
  • 8.2 B. Braun Melsungen AG
    • 8.2.1 Company Overview
    • 8.2.2 Financial Analysis
    • 8.2.3 Segmental Analysis
    • 8.2.4 Research & Development Expense
    • 8.2.5 Recent strategies and developments:
      • 8.2.5.1 Product Launches and Product Expansions:
      • 8.2.5.2 Partnerships, Collaborations, and Agreements:
  • 8.3 Baxter International, Inc.
    • 8.3.1 Company Overview
    • 8.3.2 Financial Analysis
    • 8.3.3 Regional Analysis
    • 8.3.4 Research & Development Expense
    • 8.3.5 Recent strategies and developments:
      • 8.3.5.1 Product Launches and Product Expansions:
  • 8.4 Pfizer, Inc.
    • 8.4.1 Company Overview
    • 8.4.2 Segmental and Regional Analysis
    • 8.4.3 Research & Development Expense
    • 8.4.4 Recent strategies and developments:
      • 8.4.4.1 Acquisition and Mergers:
  • 8.5 Nestle S.A.
    • 8.5.1 Company Overview
    • 8.5.2 Financial Analysis
    • 8.5.3 Segmental and Regional Analysis
    • 8.5.4 Research& Development Expense
    • 8.5.5 Recent strategies and developments:
      • 8.5.5.1 Partnerships, Collaborations, and Agreements:
      • 8.5.5.2 Product Launches and Product Expansions:
      • 8.5.5.3 Geographical Expansions:
  • 8.6 Lonza Group AG
    • 8.6.1 Company Overview
    • 8.6.2 Financial Analysis
    • 8.6.3 Segmental and Regional Analysis
    • 8.6.4 Research & Development Expense
    • 8.6.5 Recent strategies and developments:
      • 8.6.5.1 Partnerships, Collaborations, and Agreements:
      • 8.6.5.2 Product Launches and Product Expansions:
      • 8.6.5.3 Acquisition and Mergers:
  • 8.7 BASF SE
    • 8.7.1 Company Overview
    • 8.7.2 Financial Analysis
    • 8.7.3 Segmental and Regional Analysis
    • 8.7.4 Research & Development Expense
    • 8.7.5 Recent strategies and developments:
      • 8.7.5.1 Partnerships, Collaborations, and Agreements:
  • 8.8 Ajinomoto Co., Inc.
    • 8.8.1 Company Overview
    • 8.8.2 Financial Analysis
    • 8.8.3 Segmental & Regional Analysis
    • 8.8.4 Research & Development Expenses
    • 8.8.5 Recent strategies and developments:
      • 8.8.5.1 Partnerships, Collaborations, and Agreements:
      • 8.8.5.2 Acquisition and Mergers:
  • 8.9 Perrigo Company PLC
    • 8.9.1 Company Overview
    • 8.9.2 Financial Analysis
    • 8.9.3 Segmental and Regional Analysis
    • 8.9.4 Research & Development Expense
  • 8.1 Hero Nutritionals, Inc.
    • 8.10.1 Company Overview

LIST OF TABLES

  • TABLE 1 NORTH AMERICA CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
  • TABLE 2 NORTH AMERICA CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
  • TABLE 3 PARTNERSHIPS, COLLABORATIONS AND AGREEMENTS- CLINICAL NUTRITION MARKET
  • TABLE 4 PRODUCT LAUNCHES AND PRODUCT EXPANSIONS- CLINICAL NUTRITION MARKET
  • TABLE 5 MERGERS & ACQUISITIONS - CLINICAL NUTRITION MARKET
  • TABLE 6 GEOGRAPHICAL EXPANSIONS - CLINICAL NUTRITION MARKET
  • TABLE 7 NORTH AMERICA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
  • TABLE 8 NORTH AMERICA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
  • TABLE 9 NORTH AMERICA ORAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 10 NORTH AMERICA ORAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 11 NORTH AMERICA ENTERAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 12 NORTH AMERICA ENTERAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 13 NORTH AMERICA PARENTERAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 14 NORTH AMERICA PARENTERAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 15 NORTH AMERICA CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 16 NORTH AMERICA CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 17 NORTH AMERICA CANCER MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 18 NORTH AMERICA CANCER MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 19 NORTH AMERICA NEUROLOGICAL DISEASES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 20 NORTH AMERICA NEUROLOGICAL DISEASES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 21 NORTH AMERICA GASTROINTESTINAL DISORDERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 22 NORTH AMERICA GASTROINTESTINAL DISORDERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 23 NORTH AMERICA METABOLIC DISORDERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 24 NORTH AMERICA METABOLIC DISORDERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 25 NORTH AMERICA OTHER APPLICATIONS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 26 NORTH AMERICA OTHER APPLICATIONS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 27 NORTH AMERICA CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
  • TABLE 28 NORTH AMERICA CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
  • TABLE 29 NORTH AMERICA ADULTS CLINICAL NUTRITION MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 30 NORTH AMERICA ADULTS CLINICAL NUTRITION MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 31 NORTH AMERICA PEDIATRIC MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 32 NORTH AMERICA PEDIATRIC MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 33 NORTH AMERICA GERIATRIC MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 34 NORTH AMERICA GERIATRIC MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 35 NORTH AMERICA CLINICAL NUTRITION MARKET BY COUNTRY, 2016 - 2019, USD MILLION
  • TABLE 36 NORTH AMERICA CLINICAL NUTRITION MARKET BY COUNTRY, 2020 - 2026, USD MILLION
  • TABLE 37 US CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
  • TABLE 38 US CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
  • TABLE 39 US CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
  • TABLE 40 US CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
  • TABLE 41 US CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 42 US CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 43 US CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
  • TABLE 44 US CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
  • TABLE 45 CANADA CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
  • TABLE 46 CANADA CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
  • TABLE 47 CANADA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
  • TABLE 48 CANADA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
  • TABLE 49 CANADA CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 50 CANADA CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 51 CANADA CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
  • TABLE 52 CANADA CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
  • TABLE 53 MEXICO CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
  • TABLE 54 MEXICO CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
  • TABLE 55 MEXICO CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
  • TABLE 56 MEXICO CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
  • TABLE 57 MEXICO CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 58 MEXICO CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 59 MEXICO CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
  • TABLE 60 MEXICO CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
  • TABLE 61 REST OF NORTH AMERICA CLINICAL NUTRITION MARKET, 2016 - 2019, USD MILLION
  • TABLE 62 REST OF NORTH AMERICA CLINICAL NUTRITION MARKET, 2020 - 2026, USD MILLION
  • TABLE 63 REST OF NORTH AMERICA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
  • TABLE 64 REST OF NORTH AMERICA CLINICAL NUTRITION MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
  • TABLE 65 REST OF NORTH AMERICA CLINICAL NUTRITION MARKET BY APPLICATION, 2016 - 2019, USD MILLION
  • TABLE 66 REST OF NORTH AMERICA CLINICAL NUTRITION MARKET BY APPLICATION, 2020 - 2026, USD MILLION
  • TABLE 67 REST OF NORTH AMERICA CLINICAL NUTRITION MARKET BY END USER, 2016 - 2019, USD MILLION
  • TABLE 68 REST OF NORTH AMERICA CLINICAL NUTRITION MARKET BY END USER, 2020 - 2026, USD MILLION
  • TABLE 69 KEY INFORMATION - ABBOTT LABORATORIES
  • TABLE 70 KEY INFORMATION - B. BRAUN MELSUNGEN AG
  • TABLE 71 KEY INFORMATION - BAXTER INTERNATIONAL, INC.
  • TABLE 72 KEY INFORMATION - PFIZER, INC.
  • TABLE 73 KEY INFORMATION - NESTLE S.A.
  • TABLE 74 KEY INFORMATION - LONZA GROUP AG
  • TABLE 75 KEY INFORMATION - BASF SE
  • TABLE 76 KEY INFORMATION -AJINOMOTO CO., INC.
  • TABLE 77 KEY INFORMATION - PERRIGO COMPANY PLC
  • TABLE 78 KEY INFORMATION - HERO NUTRITIONALS, INC.

LIST OF FIGURES

  • FIG 1 METHODOLOGY FOR THE RESEARCH
  • FIG 2 KBV CARDINAL MATRIX
  • FIG 3 KEY LEADING STRATEGIES: PERCENTAGE DISTRIBUTION (2016-2020)
  • FIG 4 KEY STRATEGIC MOVE: (PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS : 2016, JAN - 2019, DEC) LEADING PLAYERS
  • FIG 5 KEY STRATEGIC MOVE: (PRODUCT LAUNCHES AND PRODUCT EXPANSIONS : 2016, MAR - 2019, OCT) LEADING PLAYERS
  • FIG 6 RECENT STRATEGIES AND DEVELOPMENTS: ABBOTT LABORATORIES
  • FIG 7 RECENT STRATEGIES AND DEVELOPMENTS: B. BRAUN MELSUNGEN AG
  • FIG 8 RECENT STRATEGIES AND DEVELOPMENTS: NESTLE S.A.
  • FIG 9 RECENT STRATEGIES AND DEVELOPMENTS: LONZA GROUP AG
  • FIG 10 RECENT STRATEGIES AND DEVELOPMENTS: AJINOMOTO CO., INC.
Back to Top